RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,193,212 | -33.0% | 1,568,753 | 0.0% | 0.85% | -20.0% |
| Q2 2023 | $19,703,537 | -23.7% | 1,568,753 | 0.0% | 1.06% | -26.1% |
| Q1 2023 | $25,837,362 | +10.2% | 1,568,753 | 0.0% | 1.43% | +5.3% |
| Q4 2022 | $23,437,170 | -33.2% | 1,568,753 | 0.0% | 1.36% | -24.1% |
| Q3 2022 | $35,093,000 | +33.6% | 1,568,753 | 0.0% | 1.79% | +25.7% |
| Q2 2022 | $26,277,000 | -44.0% | 1,568,753 | 0.0% | 1.43% | -6.4% |
| Q1 2022 | $46,953,000 | -2.3% | 1,568,753 | +0.3% | 1.52% | +31.3% |
| Q4 2021 | $48,036,000 | -7.2% | 1,564,173 | -4.7% | 1.16% | -5.5% |
| Q3 2021 | $51,756,000 | -22.6% | 1,641,497 | -10.1% | 1.23% | -9.8% |
| Q2 2021 | $66,845,000 | +23.3% | 1,826,876 | +16.5% | 1.36% | -37.7% |
| Q1 2021 | $54,222,000 | -27.6% | 1,568,486 | -12.9% | 2.19% | -39.1% |
| Q4 2020 | $74,870,000 | -2.4% | 1,801,490 | 0.0% | 3.59% | -0.3% |
| Q3 2020 | $76,725,000 | – | 1,801,490 | – | 3.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |